Novartis AG (NYSE:NVS)

87.55
Delayed Data
As of Apr 09
 +0.56 / +0.64%
Today’s Change
77.04
Today|||52-Week Range
98.52
-7.29%
Year-to-Date
Novartis (NVS) Teams Up With Artios for Radioligand Therapies
Apr 08 / Zacks.com - Paid Partner Content
bluebird (BLUE), Bristol Myers CAR T Cell Therapy Gets FDA Nod
Mar 30 / Zacks.com - Paid Partner Content
AbbVie (ABBV) Seeks Skyrizi Approval for Psoriatic Arthritis
Apr 08 / Zacks.com - Paid Partner Content
Roche's (RHHBY) SMA Treatment Evrysdi Secures EC Approval
Mar 30 / Zacks.com - Paid Partner Content
Are Ultra-High Drug Prices Sustainable?
Apr 01 / MotleyFool.com - Paid Partner Content
Novartis (NVS) Gets EC Nod For Kesimpta in Relapsing Forms of MS
Mar 30 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close86.99
Today’s open87.16
Day’s range87.16 - 87.67
Volume1,792,462
Average volume (3 months)1,968,914
Market cap$194.3B
Data as of 4:00pm ET, 04/09/2021

Growth & Valuation

Earnings growth (last year)+15.91%
Earnings growth (this year)+10.04%
Earnings growth (next 5 years)+8.67%
Revenue growth (last year)+2.95%
P/E ratio24.9
Price/Sales4.43
Price/Book3.43

Competitors

 Today’s
change
Today’s
% change
MRKMerck+0.85+1.13%
PFEPfizer+0.64+1.78%
ABBVAbbVie+1.43+1.35%
LLYEli Lilly and Co+1.86+1.02%
Data as of 5:29pm ET, 04/09/2021

Financials

Next reporting dateApril 27, 2021
EPS forecast (this quarter)$1.55
Annual revenue (last year)$48.9B
Annual profit (last year)$8.1B
Net profit margin16.59%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
Basel, Basel-stadt (basle Town)

Forecasts